Explore more publications!
East Timor Technology Press
Got News to Share?

East Timor Technology Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on East Timor Technology Press.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 20, 2025

Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican’s 10th Anniversary World Changers Summit
October 20, 2025

Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican’s 10th Anniversary World Changers Summit

Indeterminate GlobeNewswire
AI Maverick Intel, Inc. Announces New Trading Symbol “AIMV” Effective Oct. 20, 2025
October 20, 2025

AI Maverick Intel, Inc. Announces New Trading Symbol “AIMV” Effective Oct. 20, 2025

Indeterminate GlobeNewswire
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
October 20, 2025

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma

Indeterminate GlobeNewswire
Medicenna Therapeutics Announces Participation in Upcoming Conferences
October 20, 2025

Medicenna Therapeutics Announces Participation in Upcoming Conferences

Indeterminate GlobeNewswire
BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease
October 20, 2025

BPGbio and Icahn School of Medicine at Mount Sinai Publish Landmark Study on the Living Human Brain, Unlocking New Molecular Insights Into Neurodegenerative Disease

Indeterminate GlobeNewswire
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
October 20, 2025

SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System

Indeterminate GlobeNewswire
BioCryst to Report Third Quarter 2025 Financial Results on November 3
October 20, 2025

BioCryst to Report Third Quarter 2025 Financial Results on November 3

Indeterminate GlobeNewswire
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 20, 2025

Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
Castellum, Inc. to Attend the 2025 Maxim Growth Summit
October 20, 2025

Castellum, Inc. to Attend the 2025 Maxim Growth Summit

Indeterminate GlobeNewswire
Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones
October 20, 2025

Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones

Indeterminate GlobeNewswire
Datavault AI (NASDAQ: DVLT) Partners with Max International AG to Launch Swiss Digital RWA Exchange, Overcoming Barriers to Institutional Tokenization
October 20, 2025

Datavault AI (NASDAQ: DVLT) Partners with Max International AG to Launch Swiss Digital RWA Exchange, Overcoming Barriers to Institutional Tokenization

Indeterminate GlobeNewswire
Datavault AI (NASDAQ: DVLT) Partners with Max International AG to Launch Swiss Digital RWA Exchange, Overcoming Barriers to Institutional Tokenization
October 20, 2025

Datavault AI (NASDAQ: DVLT) Partners with Max International AG to Launch Swiss Digital RWA Exchange, Overcoming Barriers to Institutional Tokenization

Indeterminate GlobeNewswire
Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025
October 20, 2025

Biodesix to Report Third Quarter 2025 Financial Results on November 3, 2025

Indeterminate GlobeNewswire
Micropep Supercharges Peptide Innovation with Krisalix: A Groundbreaking AI-Powered Platform
October 20, 2025

Micropep Supercharges Peptide Innovation with Krisalix: A Groundbreaking AI-Powered Platform

Indeterminate GlobeNewswire
Keros Therapeutics Commences Issuer Tender Offer to Repurchase up to $194.4 Million Shares
October 20, 2025

Keros Therapeutics Commences Issuer Tender Offer to Repurchase up to $194.4 Million Shares

Indeterminate GlobeNewswire
Brothers, 19 and 20, Stanford dropouts, raise $4.1M in oversubscribed seed round to build Golpo AI and reimagine AI video generation
October 20, 2025

Brothers, 19 and 20, Stanford dropouts, raise $4.1M in oversubscribed seed round to build Golpo AI and reimagine AI video generation

Indeterminate GlobeNewswire
Aicuris Presents Positive Phase 2 Results for Pritelivir and Favorable Phase 1 Safety Data for AIC468 at ID Week 2025
October 20, 2025

Aicuris Presents Positive Phase 2 Results for Pritelivir and Favorable Phase 1 Safety Data for AIC468 at ID Week 2025

Indeterminate GlobeNewswire
Angelini Ventures Deepens Commitment to CoMind, a Neurotech Redefining Brain Monitoring, with Participation in $60 Million Round Bringing Total Funding to $102.5 Million
October 20, 2025

Angelini Ventures Deepens Commitment to CoMind, a Neurotech Redefining Brain Monitoring, with Participation in $60 Million Round Bringing Total Funding to $102.5 Million

Indeterminate GlobeNewswire
Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with Endocrine-Based Therapy
October 20, 2025

Patient-Reported Outcomes from VERITAC-2 Clinical Trial Support Clinical Benefit of Vepdegestrant in Patients with ESR1-Mutated, ER+/HER2- Advanced or Metastatic Breast Cancer Previously Treated with Endocrine-Based Therapy

Indeterminate GlobeNewswire
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
October 20, 2025

ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions